NSC |
Compound |
Enrichment |
Correlation |
NSC 750493 |
2-(2-hydroxyphenyl)-3-[5-(1H-imidazol-1-ylmethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-one |
0.0260391472224207 |
0.03471594 |
NSC 761130 |
(E)-6-chloro-3-((2-(4-fluorophenyl)imidazo[1,2-a]pyridin-3-yl)methylene)indolin-2-one |
0.0260391472224207 |
0.23486585 |
NSC 107043 |
Null |
0.0267520285931239 |
0.24054825 |
NSC 113423 |
NSC 113423 |
0.0267520285931239 |
0.33435431 |
NSC 132277 |
Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) |
0.0267520285931239 |
0.33850668 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0267520285931239 |
0.34488792 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0267520285931239 |
-0.17709613 |
NSC 15795 |
Null |
0.0267520285931239 |
0.11865343 |
NSC 339705 |
5H-Indeno[1,2-c]isoquinoline-5,11(6H)-dione, 6-(2-hydroxyethyl)- |
0.0267520285931239 |
0.17397094 |
NSC 372939 |
Null |
0.0267520285931239 |
0.35493123 |